Literature DB >> 29317078

The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old.

Jeremy M Silverman1, James Schmeidler2.   

Abstract

For some cardiovascular risk factors, association with risk for cognitive impairment observed in early old age is reduced, or paradoxically even reversed, as age of outcome increases. Successful cognitive aging is intact cognition in the oldest-old; we define resistant successful cognitive aging as successful cognitive aging despite high risk. The protected survivor model posits that a minority of the general population has a protective factor that mitigates the negative effect of a risk factor on successful cognitive aging for the unprotected majority. As age increases, differential failure rates increase the proportion of survivors with protection. Among the unprotected, the proportion with low risk increases, but among those with protection, high risk and low risk do not differ. Due to differential mortality, half the survivors are eventually protected - a majority among those with high risk, and a minority among those with low risk. According to the protective survivor model, an example of Simpson's paradox, the association of the risk factor with survival does not change within an individual, but the association in the surviving population changes as its age increases. We created quantitative illustrations of a simplified protected survivor model applied to successful cognitive aging to explain how the usual association of a risk factor with cognitive decline is reversed in the very old. In the illustrations, probability of subsequent survival was higher for survivors with high risk (mostly protected) than low risk (mostly not protected), an example of Simpson's paradox. Resistance to disease despite the presence of risk factors is consistent with the presence of countervailing protection. Based on the protected survivor model, we hypothesize that studies seeking protective factors against cognitive decline will be more effective by limiting a successful cognitive aging sample to resistant successful cognitive aging - to contrast with a sample without successful cognitive aging.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 29317078      PMCID: PMC5927359          DOI: 10.1016/j.mehy.2017.10.022

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  41 in total

1.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Martina Chiappelli; Fausta Montesi; Emanuela Tumini; Erminia Mariani; Federico Licastro; Christopher Patterson
Journal:  Neurobiol Aging       Date:  2006-09-29       Impact factor: 4.673

2.  Leisure activities and the risk of amnestic mild cognitive impairment in the elderly.

Authors:  J Verghese; A LeValley; C Derby; G Kuslansky; M Katz; C Hall; H Buschke; R B Lipton
Journal:  Neurology       Date:  2006-02-08       Impact factor: 9.910

3.  Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars.

Authors:  Nancy S Jenny; Benjamin French; Alice M Arnold; Elsa S Strotmeyer; Mary Cushman; Paulo H M Chaves; Jingzhong Ding; Linda P Fried; Stephen B Kritchevsky; Dena E Rifkin; Mark J Sarnak; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-24       Impact factor: 6.053

4.  Nutritional biomarkers and subsequent cognitive decline among community-dwelling older Japanese: a prospective study.

Authors:  Yu Taniguchi; Shoji Shinkai; Mariko Nishi; Hiroshi Murayama; Yu Nofuji; Hiroto Yoshida; Yoshinori Fujiwara
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-02-02       Impact factor: 6.053

5.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

6.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

7.  The 32-year relationship between cholesterol and dementia from midlife to late life.

Authors:  M M Mielke; P P Zandi; H Shao; M Waern; S Östling; X Guo; C Björkelund; L Lissner; I Skoog; D R Gustafson
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

8.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12

9.  Inflammation and rate of cognitive change in high-functioning older adults.

Authors:  Dawn E Alley; Eileen M Crimmins; Arun Karlamangla; Peifeng Hu; Teresa E Seeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-01       Impact factor: 6.053

10.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study.

Authors:  T Yoshitake; Y Kiyohara; I Kato; T Ohmura; H Iwamoto; K Nakayama; S Ohmori; K Nomiyama; H Kawano; K Ueda
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  3 in total

1.  Distinct age-related associations for body mass index and cognition in cognitively healthy very old veterans.

Authors:  James Schmeidler; Cecilia N Mastrogiacomo; Michal S Beeri; Clive Rosendorff; Jeremy M Silverman
Journal:  Int Psychogeriatr       Date:  2019-02-05       Impact factor: 3.878

2.  Outcome age-based prediction of successful cognitive aging by total cholesterol.

Authors:  Jeremy M Silverman; James Schmeidler
Journal:  Alzheimers Dement       Date:  2018-03-05       Impact factor: 21.566

3.  Associations of hemoglobin A1c with cognition reduced for long diabetes duration.

Authors:  Jeremy M Silverman; James Schmeidler; Pearl G Lee; Neil B Alexander; Michal Schnaider Beeri; Elizabeth Guerrero-Berroa; Rebecca K West; Mary Sano; Martina Nabozny; Carolina Rodriguez Alvarez
Journal:  Alzheimers Dement (N Y)       Date:  2019-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.